Myomo

Myomo develops and markets wearable robotic devices—specifically the MyoPro line of powered arm braces—that restore function in individuals with upper-limb paralysis or weakness due to neurological injuries or disorders. The company’s products are commercially available in the US and Europe, supported by unique Medicare billing codes. Over three thousand patients have received a MyoPro device as of early 2025. Clinical results show improved independence in activities of daily living for users with conditions such as stroke, brachial plexus injury, traumatic brain injury, spinal cord injury, and other neuromuscular disabilities. The latest product evolution—the MyoPro® 2x—features enhanced donning/doffing processes and improved fit/functionality based on clinician/patient feedback.